Page 54 - Read Online

Hewitt et al. Hepatoma Res 2021;7:75 https://dx.doi.org/10.20517/2394-5079.2021.83 Page 17 of 19

73. Popescu GA, Alexandrescu ST, Grigorie RT, Stoica L, Apavaloaie CA, Hrehoreţ D. GOOD TO KNOW: the ALPPS procedure -
embracing a new technique. Chirurgia (Bucur) 2017;112:332-41. DOI PubMed
74. Liu Y, Yang Y, Gu S, Tang K. A systematic review and meta-analysis of associating liver partition and portal vein ligation for staged
hepatectomy (ALPPS) versus traditional staged hepatectomy. Medicine (Baltimore) 2019;98:e15229. DOI PubMed PMC
75. May BJ, Madoff DC. Portal vein embolization: rationale, technique, and current application. Semin Intervent Radiol 2012;29:81-9.
DOI PubMed PMC
76. Abulkhir A, Limongelli P, Healey AJ, et al. Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg
2008;247:49-57. DOI PubMed
77. Akateh C, Ejaz AM, Pawlik TM, Cloyd JM. Neoadjuvant treatment strategies for intrahepatic cholangiocarcinoma. World J Hepatol
2020;12:693-708. DOI PubMed PMC
78. Kato A, Shimizu H, Ohtsuka M, et al. Downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer
patients treated with gemcitabine plus cisplatin combination therapy followed by radical surgery. Ann Surg Oncol 2015;22 Suppl
3:S1093-9. DOI PubMed
79. Le Roy B, Gelli M, Pittau G, et al. Neoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinoma. Br J Surg
2018;105:839-47. DOI PubMed
80. Rizzo A, Brandi G. Neoadjuvant therapy for cholangiocarcinoma: a comprehensive literature review. Cancer Treat Res Commun
2021;27:100354. DOI PubMed
81. Konstantinidis IT, Groot Koerkamp B, Do RK, et al. Unresectable intrahepatic cholangiocarcinoma: systemic plus hepatic arterial
infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone. Cancer 2016;122:758-65.
DOI PubMed PMC
82. Cercek A, Boerner T, Tan BR, et al. Assessment of hepatic arterial infusion of floxuridine in combination with systemic gemcitabine
and oxaliplatin in patients with unresectable intrahepatic cholangiocarcinoma: a phase 2 clinical trial. JAMA Oncol 2020;6:60-7. DOI
PubMed PMC
83. Imamura H, Seyama Y, Kokudo N, et al. One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg
2003;138:1198-206; discussion 1206. DOI PubMed
84. Dimick JB, Cowan JA Jr, Knol JA, Upchurch GR Jr. Hepatic resection in the United States: indications, outcomes, and hospital
procedural volumes from a nationally representative database. Arch Surg 2003;138:185-91. DOI PubMed
85. Colavita PD, Tsirline VB, Belyansky I, et al. Regionalization and outcomes of hepato-pancreato-biliary cancer surgery in USA. J
Gastrointest Surg 2014;18:532-41. DOI PubMed
86. Kinoshita H, Sakai K, Hirohashi K, Igawa S, Yamasaki O, Kubo S. Preoperative portal vein embolization for hepatocellular
carcinoma. World J Surg 1986;10:803-8. DOI PubMed
87. Ebata T, Mizuno T, Yokoyama Y, Igami T, Sugawara G, Nagino M. Surgical resection for Bismuth type IV perihilar
cholangiocarcinoma. Br J Surg 2018;105:829-38. DOI PubMed
88. Abbas S, Sandroussi C. Systematic review and meta-analysis of the role of vascular resection in the treatment of hilar
cholangiocarcinoma. HPB (Oxford) 2013;15:492-503. DOI PubMed PMC
89. Leen E, Ceccotti P, Moug SJ, et al. Potential value of contrast-enhanced intraoperative ultrasonography during partial hepatectomy
for metastases: an essential investigation before resection? Ann Surg 2006;243:236-40. DOI PubMed PMC
90. Yin L, Zhao S, Zhu H, Ji G, Zhang X. Primary tumor resection improves survival in patients with multifocal intrahepatic
cholangiocarcinoma based on a population study. Sci Rep 2021;11:12166. DOI PubMed PMC
91. Ribero D, Pinna AD, Guglielmi A, et al; Italian Intrahepatic Cholangiocarcinoma Study Group. Surgical approach for long-term
survival of patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis of 434 patients. Arch Surg 2012;147:1107-13.
DOI PubMed
92. Spolverato G, Yakoob MY, Kim Y, et al. The Impact of surgical margin status on long-term outcome after resection for intrahepatic
cholangiocarcinoma. Ann Surg Oncol 2015;22:4020-8. DOI PubMed
93. Raab R, Schlitt HJ, Oldhafer KJ, Bornscheuer A, Lang H, Pichlmayr R. Ex-vivo resection techniques in tissue-preserving surgery for
liver malignancies. Langenbecks Arch Surg 2000;385:179-84. DOI PubMed
94. Zawistowski M, Nowaczyk J, Jakubczyk M, Domagała P. Outcomes of ex vivo liver resection and autotransplantation: a systematic
review and meta-analysis. Surgery 2020;168:631-42. DOI PubMed
95. Farges O, Fuks D, Boleslawski E, et al. Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a
multicenter study by the AFC-IHCC-2009 study group. Ann Surg 2011;254:824-29; discussion 830. DOI PubMed
96. Shimada K, Sano T, Sakamoto Y, Esaki M, Kosuge T, Ojima H. Clinical impact of the surgical margin status in hepatectomy for
solitary mass-forming type intrahepatic cholangiocarcinoma without lymph node metastases. J Surg Oncol 2007;96:160-5. DOI
PubMed
97. Tamandl D, Herberger B, Gruenberger B, Puhalla H, Klinger M, Gruenberger T. Influence of hepatic resection margin on recurrence
and survival in intrahepatic cholangiocarcinoma. Ann Surg Oncol 2008;15:2787-94. DOI PubMed
98. Hong JC, Jones CM, Duffy JP, et al. Comparative analysis of resection and liver transplantation for intrahepatic and hilar
cholangiocarcinoma: a 24-year experience in a single center. Arch Surg 2011;146:683-9. DOI PubMed
99. Nuzzo G, Giuliante F, Ardito F, et al; Italian Chapter of the International Hepato-Pancreato-Biliary Association. Improvement in
perioperative and long-term outcome after surgical treatment of hilar cholangiocarcinoma: results of an Italian multicenter analysis of
440 patients. Arch Surg 2012;147:26-34. DOI PubMed
100. Hasegawa S, Ikai I, Fujii H, Hatano E, Shimahara Y. Surgical resection of hilar cholangiocarcinoma: analysis of survival and